tRNA binding to programmed ribosomes increases the ribosomal affinity for tuberactinomycin O

Area of Science:

• Molecular Biology
• Biochemistry
• Microbiology

Background:

• Tuberactinomycin O is an antibiotic with potential therapeutic applications.
• Understanding its interaction with bacterial ribosomes is crucial for elucidating its mechanism of action.
• Ribosome-antibiotic interactions are key targets for developing new antimicrobial agents.

Purpose of the Study:

• To investigate the binding characteristics of 14C-labelled tuberactinomycin O to non-programmed ribosomes.
• To determine the influence of ribosomal P-site occupancy and other antibiotics on tuberactinomycin O binding.
• To elucidate the specific interactions of tuberactinomycin O with the ribosome.

Main Methods:

• Equilibrium dialysis was employed to analyze the binding of 14C-labelled tuberactinomycin O.
• Binding assays were conducted under controlled ionic conditions with a specific drug concentration.
• The effect of deacylated tRNAPhe, various antibiotics (kanamycin, gentamicin, neomycin, chloramphenicol, tetracycline, streptomycin, puromycin, erythromycin) on tuberactinomycin O binding was assessed.

Main Results:

• Tuberactinomycin O binds to ribosomes at a stoichiometry of one drug molecule per ribosome under the tested conditions.
• Binding of deacylated tRNAPhe to the ribosomal P-site doubled the amount of tuberactinomycin O bound.
• Aminoglycoside antibiotics (kanamycin, gentamicin, neomycin) inhibited tuberactinomycin O binding, while erythromycin stimulated it; other tested antibiotics had no effect.

Conclusions:

• Ribosomal P-site occupation significantly influences tuberactinomycin O binding.
• Tuberactinomycin O's binding is modulated by specific classes of antibiotics, indicating potential overlapping or distinct binding sites.
• These findings provide insights into the molecular interactions of tuberactinomycin O with the ribosome, relevant for antibiotic development.